Danaher Corp (NY:DHR)

Danaher Soars as Leica Biosystems Unveils Groundbreaking AI-Powered Digital Pathology Solutions

October 01, 2025

New York, NY – October 1, 2025 – Shares of Danaher Corporation (NYSE: DHR) surged by a robust 6.6% today, following a significant announcement from its life sciences subsidiary, Leica Biosystems. The...

Thermo Fisher Scientific Inc. (NYSE: TMO) experienced a robust surge in its stock value today, October 1, 2025, climbing an impressive 9.79% as market optimism swelled around a series of recent...

Topics Artificial Intelligence

Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism

October 01, 2025

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.

Topics Artificial Intelligence Economy Government

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years ↗

October 01, 2025

Via Benzinga

Topics Government

Why Danaher (DHR) Stock Is Trading Up Today

October 01, 2025

Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 6.6% in the afternoon session after its subsidiary, Leica Biosystems, announced the launch of new artificial intelligence...

In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Wednesday's session.

Topics Artificial Intelligence Government

10 Health Care Stocks Whale Activity In Today's Session ↗

October 01, 2025

Via Benzinga

In today's session, there are S&P500 stocks with remarkable trading volume. ↗

October 01, 2025

Via Chartmill

How Do Investors Really Feel About Danaher? ↗

August 27, 2025

Via Benzinga

Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Topics Government

What's going on in today's session: S&P500 movers ↗

September 30, 2025

Via Chartmill

Discover which S&P500 stocks are making waves on Tuesday. ↗

September 30, 2025

Curious about the top performers within the S&P500 index in the middle of the day on Tuesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

Via Chartmill

3 Reasons to Sell DHR and 1 Stock to Buy Instead

September 30, 2025

Over the last six months, Danaher’s shares have sunk to $186.35, producing a disappointing 9.1% loss - a stark contrast to the S&P 500’s 18.6% gain. This may have investors wondering how to approach...

Quantum Leap: DTU Breakthroughs Propel Photonic Computing and Graphene Biosensors to the Forefront

Topics Stocks

September 29, 2025

In a week poised to redefine the landscape of advanced technology, the Technical University of Denmark (DTU) has unveiled two monumental advancements set to send ripples through the financial markets...

DANAHER INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Danaher Corporation - DHR

Topics Artificial Intelligence

September 26, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

A Look Into Danaher Inc's Price Over Earnings ↗

September 26, 2025

In the current market session, Danaher Inc. (NYSE: DHR) price is at $183.36, after a 1.05% spike. However, over the past month, the stock fell by 10.91%, and in the past year, by 34.05%.

Via Benzinga

Danaher Corp (NYSE:DHR) Passes the Caviar Cruise Quality Investment Screen ↗

September 26, 2025

Danaher Corp (DHR) excels as a quality investment, showing strong revenue growth, a high 38.86% ROIC, solid financial health, and excellent cash flow conversion.

Via Chartmill

Trump Administration Review Targets Medical Supply Chain Vulnerabilities ↗

September 25, 2025

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—including PPE, consumables, and medical devices—to assess reliance on foreign...

Via Benzinga

Topics Economy Government Supply Chain

1 of Wall Street’s Favorite Stock on Our Watchlist and 2 Facing Headwinds

September 24, 2025

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because...

Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

September 20, 2025

From The Rosen Law Firm PA

DANAHER INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Danaher Corporation - DHR

September 17, 2025

From Kahn Swick & Foti, LLC

Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

September 17, 2025

From The Rosen Law Firm PA

In a development that has sent ripples of concern through financial markets, the U.S. Treasury yield curve underwent a significant un-inversion in April 2025, following its longest inversion in...

The Unsettling Normalization: Yield Curve's Un-Inversion Signals Potential Storm Ahead

September 16, 2025

Unpacking Q2 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks

Topics Bonds Economy

September 14, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Danaher (NYSE:DHR) and the rest...

Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Topics Economy

September 11, 2025

From The Rosen Law Firm PA

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory...

3 Healthcare Stocks We’re Skeptical Of

September 08, 2025

RBC Capital upgraded Bio-Techne, citing M&A confidence, margin gains, and growth potential after a sharp stock drop and alignment with sector valuations.

Topics Stocks

Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry Point ↗

September 03, 2025

Via Benzinga

DANAHER INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Danaher Corporation - DHR

September 02, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

3 Low-Volatility Stocks We Keep Off Our Radar

August 27, 2025

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere.